drugset / Trial / NCT01721070

Effect of Ketoconazole on Sufentanil NanoTab Pharmacokinetics

NCT01721070

Phase 1 Completed 19 enrolled Talphera, Inc
Non-randomizedSingle-groupOpen-labelBasic science

Summary

Evaluate the effect of taking ketoconazole on sufentanil plasma concentrations following sublingual administration of sufentanil NanoTab.

Timeline

Start
2012-11
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoconazole Small molecule 400 mg
Subject Sufentanil Other / unclassified 15 ug Other

Indications

No indication recorded.